Epilepsy Canada Research Grant Recipient 2026

Dr. Kurt Haas, PhD

Professor, Department of Cellular & Physiological Sciences, Faculty of Medicine, University of British Columbia

Grant Project: Early-life seizures alter brain circuit formation by hijacking heightened developmental brain circuit plasticity: Opportunities for novel anti-epileptogenic therapeutics based on metaplasticity

Project Summary:

Our research project is focused on understanding how seizures alter brain development, leading to epilepsy later in life, providing insights for developing new treatments to prevent epilepsy. This work is motivated by our previous findings that while the developing brain is especially prone to seizure activity, it shows remarkable resistance to the seizure-induced brain neuronal damage and death seen in adults. However, our work also finds that the formation of functional brain circuits during development requires normal patterns of neuronal activity, suggesting that the abnormal activity associated with seizures may hijack this process.

We find that under normal conditions, brain activity driven by visual experience directs the growth, synaptic connectivity, and encoding properties of individual brain neurons, through a process called activity-dependent plasticity. Further, we have identified molecular pathways, called 'metaplasticity', that alter each neuron's plasticity response to neural activity, raising the possibility that drugs targeting metaplasticity pathways may protect the developing brain from seizure-induced alterations of neural circuit formation.

We will test this hypothesis by directly imaging and measuring the impact of seizures on the growth and synapse formation of individual neurons in the developing brains of experimental animals. Further, we will test whether seizure-induced structural changes disrupt brain circuit function and promote the development of 'seizure-prone circuits' underlying epilepsy.

Finally, we will test whether activating metaplasticity pathways can protect the developing brain from these seizure-induced effects, opening an avenue for development of a new class of 'anti-epileptogenic drugs' that suppress the progression of seizures into epilepsy.

Donor acknowledgement
An anonymous donor made this grant possible. The donor wanted to fund research in an area of epilepsy that mattered to them and chose to invest in work led by a researcher in their home province of British Columbia.

You can help advance epilepsy research in an area that matters to you. Whether you choose to give anonymously or have your gift recognized, explore ways to give.

Next
Next

THE ROBERT CONLON RESEARCH GRANT RECIPIENT